Skip to content
EU Parl WatchResearch
Projects

Vote · Roll call

Amendment 250 to article 16, after paragraph 2

Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest

Vote
Amendment 250 to article 16, after paragraph 2
Decision
No. 1 of the sitting of 20 Jan 2026
Result
141 for · 516 against · 7 abstained Rejected · roll call
Date
20 January 2026, 12:47
More facts (6)
Position
vote 15 of 43 on the decision
Requested by
roll call: The Left
Official label
A10-0272/2025 – Tomislav Sokol – Article 16, after § 2 – Am 250
Text
Report A-10-2025-0272
Dossier
2025/0102(COD)
Vote id
183253
More
Cite this page

The members file includes members in office who did not vote.

Roll-call results (EP) (opens the official site)
Link to this page

Result

The vote as recorded by name.

Result: 141 for, 516 against, 7 abstained (roll call).

Rejected · 21 % of the votes cast were for.

Groups

Members' votes, each counted in the group they belonged to on the day. No vote: in office that day, no position recorded. Majority line: the most common position. Clear line: a position with at least two thirds of the group's votes (at least 10 members voting), otherwise Divided. Cohesion: Agreement Index, 0 = evenly split, 1 = all voted the same (method).
GroupForAgainstAbst.No voteMajority lineClear lineCohesionBar
The LeftFor 39Against 0Abst. 0No vote 7 of 46Majority line ForClear line For Cohesion 1.00
GreensFor 51Against 0Abst. 0No vote 2 of 53Majority line ForClear line For Cohesion 1.00
S&DFor 32Against 91Abst. 2No vote 11 of 136Majority line AgainstClear line Against Cohesion 0.59
RenewFor 1Against 66Abst. 1No vote 7 of 75Majority line AgainstClear line Against Cohesion 0.96
EPPFor 1Against 181Abst. 0No vote 6 of 188Majority line AgainstClear line Against Cohesion 0.99
ECRFor 0Against 70Abst. 1No vote 8 of 79Majority line AgainstClear line Against Cohesion 0.98
PatriotsFor 0Against 78Abst. 0No vote 7 of 85Majority line AgainstClear line Against Cohesion 1.00
ESNFor 0Against 23Abst. 1No vote 3 of 27Majority line AgainstClear line Against Cohesion 0.94
No groupFor 17Against 7Abst. 2No vote 4 of 30Majority line —Clear line No line Cohesion —

Members who changed group are counted in the group of the day: Branko GRIMS changed group, Elena YONCHEVA changed group, Elisabetta GUALMINI changed group, Ewa ZAJĄCZKOWSKA-HERNIK changed group, Jessika VAN LEEUWEN changed group, Laurent CASTILLO changed group, Lukas SIEPER changed group, Nikola BARTŮŠEK changed group, Nikolas FARANTOURIS changed group, Pina PICIERNO changed group, Roberto VANNACCI changed group, Sander SMIT changed group, Taner KABILOV changed group.

Countries × groups

How each country’s members of each group voted.

Renew members by country who voted for, against or abstained (group at the date of the vote).
CountryForAgainstAbst.Bar
Austria020
Belgium030
Bulgaria030
Germany070
Denmark040
Estonia110
Spain010
Finland020
France0120
Ireland060
Lithuania020
Luxembourg010
Latvia010
Netherlands070
Poland010
Portugal010
Romania021
Sweden030
Slovenia020
Slovakia050

Members

Each member’s recorded position, in the group they sat in that day. Filter by country, group, position or name.

Show all 664 members

No vote recorded, 55

Members in office that day without a recorded position. No vote recorded is not the same as absent: leave, illness or chairing the sitting look the same.

Show the 55 members

Name · group that day · country

Similar votes

Roll calls that split the chamber the most similarly: r is the correlation of members’ positions, over the members who voted in both. Other votes on the same decision are left out.

Result: for–against–abstained. For: share of the votes cast. Requested by: the groups that asked for a roll call.
DateVoteKindResultForRequested byr · shared
8 Jul 2026Amendment 37 to paragraph 54 EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement (Interim report)Amendment123 for, 536 against, 8 abstained Rejected For 18 %Requested by The Leftr · shared0.87 611 voters
22 Oct 2025Amendment 391 Draft general budget of the European Union for the financial year 2026 – all sectionsAmendment108 for, 534 against, 8 abstained Rejected For 17 %Requested by The Leftr · shared0.85 605 voters
8 Jul 2026Amendment 31, adding text after paragraph 45 EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement (Interim report)Amendment118 for, 518 against, 23 abstained Rejected For 18 %Requested by The Leftr · shared0.85 603 voters
Show 7 more
Result: for–against–abstained. For: share of the votes cast. Requested by: the groups that asked for a roll call.
DateVoteKindResultForRequested byr · shared
29 Apr 2026Amendment 97 to Article 2, paragraph 1, point 2, point b Simplification of certain requirements and procedures for chemical productsAmendment123 for, 506 against, 17 abstained Rejected For 19 %Requested by The Leftr · shared0.83 599 voters
7 Jul 2026Amendment 7, adding text after paragraph 50 Competition policy – annual report 2025Amendment108 for, 468 against, 77 abstained Rejected For 17 %Requested by The Leftr · shared0.83 603 voters
7 Jul 2026Amendment 5, adding text after recital Y Recommendation on the changing geopolitical situation in East Asia and the need for closer cooperation with like-minded partners in the regionAmendment121 for, 486 against, 47 abstained Rejected For 19 %Requested by The Leftr · shared0.82 604 voters
2 Apr 2025Amendment 82, adding text after paragraph 22 Guidelines for the 2026 budget – Section IIIAmendment145 for, 529 against, 10 abstained Rejected For 21 %Requested by The Leftr · shared0.82 626 voters
9 Oct 2025Amendment 6, adding text after paragraph 6 Deliberations of the Committee on Petitions in 2024Amendment129 for, 449 against, 34 abstained Rejected For 21 %Requested by Greensr · shared0.82 568 voters
20 Jan 2026Amendment 14, adding text after paragraph 14 The 28th Regime: a new legal framework for innovative companiesAmendment81 for, 518 against, 56 abstained Rejected For 12 %Requested by The Leftr · shared0.82 650 voters
28 Apr 2026Amendment 40, adding text after paragraph 121 Interim report on the proposal for the multiannual financial framework for 2028-2034Amendment98 for, 508 against, 48 abstained Rejected For 15 %Requested by The Leftr · shared0.81 606 voters

How similarity is measured

Compare with another vote

Groups’ lines side by side, and the members who switched between the two votes.

Connections

This vote’s decision, the other votes on it, and related votes.

Show 11 connections: The decision · Other votes on this decision

The decision

Other votes on this decision

See all: Other votes on this decision

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink
https://news.eu-parl.st-solutions.dev/votes/2026-01-20/183253
Official sources
Data source
Licensed CC BY 4.0.
Retrieved
27 September 2026

Cite as

European Parliament (2026). “Amendment 250 to article 16, after paragraph 2 — Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest”. Vote, 20 January 2026. votingId 183253, reference 2025/0102(COD). EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/votes/2026-01-20/183253 (retrieved 27 September 2026). Official sources: Roll-call votes, sitting of 20 January 2026 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-RCV_EN.html; Results of votes, sitting of 20 January 2026 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-VOT_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2026-01-20, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2026-01-20/vote-results?format=application%2Fld%2Bjson (CC BY 4.0).
BibTeX 
@misc{epw-vote-2026-01-20-183253,
  author = {{European Parliament}},
  title = {{Amendment 250 to article 16, after paragraph 2 — Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest}},
  year = {2026},
  date = {2026-01-20},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/votes/2026-01-20/183253}},
  url = {https://news.eu-parl.st-solutions.dev/votes/2026-01-20/183253},
  urldate = {2026-09-27},
  publisher = {EU Parl Watch Research},
  note = {Vote. votingId 183253, reference 2025/0102(COD). Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2026-01-20-VOT\_EN.html. Data: EP Open Data API: vote results of the sitting MTG-PL-2026-01-20 (CC BY 4.0)}
}